LinkedIn Profile

Access Dova Pharmaceuticals historical Linkedin company profile data on number of followers, employee headcount and more
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
nasdaq:dova 11042846 Jan 5th, 2022 12:00AM Dova Pharmaceuticals 9.5K 47.00 Open Biotechnology Jan 5th, 2022 09:14AM Jan 5th, 2022 09:14AM Dova is a growing specialty pharmaceutical company driven by our passion for building a high-value portfolio of differentiated medicines for patients with rare diseases. Every day we work to develop and commercialize solutions that can improve patients' health and well-being in this community. The US FDA approved Dova's lead drug product in May 2018, and in June 2019, the FDA approved a second indication. In June 2019, Dova also received its first approval in the EU. Dova is headquartered in Durham, North Carolina. The company is a wholly-owned subsidiary of Swedish Orphan Biovitrum AB (publ) (Sobi). Open Open 240 Leigh Farm Road, Suite 245 Durham NC US 27707 Dova Pharmaceuticals
nasdaq:dova 11042846 Jan 4th, 2022 12:00AM Dova Pharmaceuticals 9.5K 47.00 Open Biotechnology Jan 3rd, 2022 09:36PM Jan 3rd, 2022 09:36PM Dova is a growing specialty pharmaceutical company driven by our passion for building a high-value portfolio of differentiated medicines for patients with rare diseases. Every day we work to develop and commercialize solutions that can improve patients' health and well-being in this community. The US FDA approved Dova's lead drug product in May 2018, and in June 2019, the FDA approved a second indication. In June 2019, Dova also received its first approval in the EU. Dova is headquartered in Durham, North Carolina. The company is a wholly-owned subsidiary of Swedish Orphan Biovitrum AB (publ) (Sobi). Open Open 240 Leigh Farm Road, Suite 245 Durham NC US 27707 Dova Pharmaceuticals
nasdaq:dova 11042846 Jan 3rd, 2022 12:00AM Dova Pharmaceuticals 9.5K 47.00 Open Biotechnology Jan 3rd, 2022 09:02AM Jan 3rd, 2022 09:02AM Dova is a growing specialty pharmaceutical company driven by our passion for building a high-value portfolio of differentiated medicines for patients with rare diseases. Every day we work to develop and commercialize solutions that can improve patients' health and well-being in this community. The US FDA approved Dova's lead drug product in May 2018, and in June 2019, the FDA approved a second indication. In June 2019, Dova also received its first approval in the EU. Dova is headquartered in Durham, North Carolina. The company is a wholly-owned subsidiary of Swedish Orphan Biovitrum AB (publ) (Sobi). Open Open 240 Leigh Farm Road, Suite 245 Durham NC US 27707 Dova Pharmaceuticals
nasdaq:dova 11042846 Jan 2nd, 2022 12:00AM Dova Pharmaceuticals 9.5K 47.00 Open Biotechnology Jan 2nd, 2022 03:38PM Jan 2nd, 2022 03:38PM Dova is a growing specialty pharmaceutical company driven by our passion for building a high-value portfolio of differentiated medicines for patients with rare diseases. Every day we work to develop and commercialize solutions that can improve patients' health and well-being in this community. The US FDA approved Dova's lead drug product in May 2018, and in June 2019, the FDA approved a second indication. In June 2019, Dova also received its first approval in the EU. Dova is headquartered in Durham, North Carolina. The company is a wholly-owned subsidiary of Swedish Orphan Biovitrum AB (publ) (Sobi). Open Open 240 Leigh Farm Road, Suite 245 Durham NC US 27707 Dova Pharmaceuticals
nasdaq:dova 11042846 Jan 1st, 2022 12:00AM Dova Pharmaceuticals 9.5K 47.00 Open Biotechnology Jan 1st, 2022 05:30PM Jan 1st, 2022 05:30PM Dova is a growing specialty pharmaceutical company driven by our passion for building a high-value portfolio of differentiated medicines for patients with rare diseases. Every day we work to develop and commercialize solutions that can improve patients' health and well-being in this community. The US FDA approved Dova's lead drug product in May 2018, and in June 2019, the FDA approved a second indication. In June 2019, Dova also received its first approval in the EU. Dova is headquartered in Durham, North Carolina. The company is a wholly-owned subsidiary of Swedish Orphan Biovitrum AB (publ) (Sobi). Open Open 240 Leigh Farm Road, Suite 245 Durham NC US 27707 Dova Pharmaceuticals
nasdaq:dova 11042846 Dec 31st, 2021 12:00AM Dova Pharmaceuticals 9.5K 47.00 Open Biotechnology Dec 31st, 2021 01:51PM Dec 31st, 2021 01:51PM Dova is a growing specialty pharmaceutical company driven by our passion for building a high-value portfolio of differentiated medicines for patients with rare diseases. Every day we work to develop and commercialize solutions that can improve patients' health and well-being in this community. The US FDA approved Dova's lead drug product in May 2018, and in June 2019, the FDA approved a second indication. In June 2019, Dova also received its first approval in the EU. Dova is headquartered in Durham, North Carolina. The company is a wholly-owned subsidiary of Swedish Orphan Biovitrum AB (publ) (Sobi). Open Open 240 Leigh Farm Road, Suite 245 Durham NC US 27707 Dova Pharmaceuticals
nasdaq:dova 11042846 Dec 30th, 2021 12:00AM Dova Pharmaceuticals 9.5K 47.00 Open Biotechnology Dec 30th, 2021 12:21PM Dec 30th, 2021 12:21PM Dova is a growing specialty pharmaceutical company driven by our passion for building a high-value portfolio of differentiated medicines for patients with rare diseases. Every day we work to develop and commercialize solutions that can improve patients' health and well-being in this community. The US FDA approved Dova's lead drug product in May 2018, and in June 2019, the FDA approved a second indication. In June 2019, Dova also received its first approval in the EU. Dova is headquartered in Durham, North Carolina. The company is a wholly-owned subsidiary of Swedish Orphan Biovitrum AB (publ) (Sobi). Open Open 240 Leigh Farm Road, Suite 245 Durham NC US 27707 Dova Pharmaceuticals
nasdaq:dova 11042846 Dec 29th, 2021 12:00AM Dova Pharmaceuticals 9.5K 47.00 Open Biotechnology Dec 29th, 2021 12:43PM Dec 29th, 2021 12:43PM Dova is a growing specialty pharmaceutical company driven by our passion for building a high-value portfolio of differentiated medicines for patients with rare diseases. Every day we work to develop and commercialize solutions that can improve patients' health and well-being in this community. The US FDA approved Dova's lead drug product in May 2018, and in June 2019, the FDA approved a second indication. In June 2019, Dova also received its first approval in the EU. Dova is headquartered in Durham, North Carolina. The company is a wholly-owned subsidiary of Swedish Orphan Biovitrum AB (publ) (Sobi). Open Open 240 Leigh Farm Road, Suite 245 Durham NC US 27707 Dova Pharmaceuticals
nasdaq:dova 11042846 Dec 28th, 2021 12:00AM Dova Pharmaceuticals 9.5K 47.00 Open Biotechnology Dec 28th, 2021 09:18AM Dec 28th, 2021 09:18AM Dova is a growing specialty pharmaceutical company driven by our passion for building a high-value portfolio of differentiated medicines for patients with rare diseases. Every day we work to develop and commercialize solutions that can improve patients' health and well-being in this community. The US FDA approved Dova's lead drug product in May 2018, and in June 2019, the FDA approved a second indication. In June 2019, Dova also received its first approval in the EU. Dova is headquartered in Durham, North Carolina. The company is a wholly-owned subsidiary of Swedish Orphan Biovitrum AB (publ) (Sobi). Open Open 240 Leigh Farm Road, Suite 245 Durham NC US 27707 Dova Pharmaceuticals
nasdaq:dova 11042846 Dec 27th, 2021 12:00AM Dova Pharmaceuticals 9.5K 47.00 Open Biotechnology Dec 27th, 2021 11:31AM Dec 27th, 2021 11:31AM Dova is a growing specialty pharmaceutical company driven by our passion for building a high-value portfolio of differentiated medicines for patients with rare diseases. Every day we work to develop and commercialize solutions that can improve patients' health and well-being in this community. The US FDA approved Dova's lead drug product in May 2018, and in June 2019, the FDA approved a second indication. In June 2019, Dova also received its first approval in the EU. Dova is headquartered in Durham, North Carolina. The company is a wholly-owned subsidiary of Swedish Orphan Biovitrum AB (publ) (Sobi). Open Open 240 Leigh Farm Road, Suite 245 Durham NC US 27707 Dova Pharmaceuticals

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.